Ability to Schedule On-site Testing, Pay and Receive Results Online Within Minutes
Miami, FL – February 16, 2022 – Globe Newswire via NewMediaWire – Progressive Care Inc. (OTCQB: RXMD) (the “Company”), a personalized healthcare services and technology provider, is pleased to announce its expansion into corporate-focused services with enhanced technological capabilities to help businesses manage COVID-19 testing and vaccination in the workplace.
Progressive Care’s PharmcoRx.com platform now allows business managers or their appointed administrators to schedule COVID-19 testing for large groups online, select a preferred testing location or request an on-site visit, receive and securely share their employees’ testing results, as well as securely communicate with the pharmacy’s lab staff in real time.
Carlos Rangel, Head of Digital Transformation of Progressive Care, stated, “We have been able to provide our institutional clients with a complete platform for COVID-19 management in the workplace including the performance of on-site testing and vaccinations with real-time reporting through our patient portal. We look forward to continuing to build strong relationships in the corporate space and we are excited about our technology capabilities.”
Due to the latest COVID-19 surge, organizations are turning to companies such as Progressive Care for COVID-19 management solutions that provide COVID-19 PCR and Antigen test results within 15 to 30 minutes. The Company’s COVID-19 team has established working relationships with top entertainment and media production companies in the United States, large manufacturers, embassies, and Fortune 500 companies. Progressive Care currently operates over 40 COVID-19 rapid PCR test analyzers and has generated over $4 million in testing revenue in 2021. Its online COVID-19 platform comes as the preface of a more comprehensive initiative to bring rapid COVID-19 point of care PCR testing nationwide.
Alan Jay Weisberg, CEO and Chairman of the Board, added, “Despite adverse labor conditions and ongoing challenges brought by COVID-19 variants, our team of dedicated professionals was able to successfully deliver on our mission to protect workplaces through the continued development of our digital platform capabilities to stay at the vanguard of healthcare technology.”
Progressive Care, Inc.
Progressive Care, Inc. (OTCQB: RXMD), through its subsidiaries, is a Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications,
medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.
For more information about Progressive Care, please visit the company’s website.
Connect and stay in touch with us on social media:
Progressive Care Inc.
https://www.progressivecareus.com/ https://twitter.com/ProgressCareUS
PharmCoRx https://www.pharmcorx.com/ https://twitter.com/PharmCoRx
ClearMetrX https://www.clearmetrx.com/ https://www.facebook.com/clearmetrx/
Forward-Looking Statements:
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance, and opportunities that involve substantial risks and uncertainties. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Public Relations Contact:
Carlos Rangel
carlosr@pharmcorx.com
Investor Relations Contact:
ClearThink Capital
nyc@clearthink.capital
Copyright 2022 © Progressive care inc.
Forward-looking Statements – This website contains forward-looking statements about our business. These forward-looking statements do not relate strictly to historical or current facts. Forward-looking statements involve risks and uncertainties and include statements regarding, among other things, our projected revenue growth and profitability, our growth strategies and opportunity, anticipated trends in our market and our anticipated needs for working capital. Forward-looking statements are generally identifiable by the use of words like “may,” “will,” “should,” “anticipate,” “estimate,” “plans,” “potential,” “projects,” “continuing,” “ongoing,” “expects,” “management believes,” “we believe,” “we intend” or the negative of these words or other variations on these words or comparable terminology. You should not put undue reliance on these forward-looking statements. Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause actual results to differ materially from those reflected in such statements including: risks associated with current and potential future healthcare reforms; risks relating to technology failures or breaches; aspects of our business which are outside, risks relating to management and key personnel changes including attracting and retaining key personnel; failure to comply with legal and regulatory requirements; risks relating to access to capital and credit markets; risks related to indebtedness; exposure to claims and liabilities; changes in industry pricing benchmarks; and other risks and uncertainties that are described in the Risk Factors section of our recently filed Form 10-12G, including the presentation of financial statements and notes thereto, and other reports we have filed with the U.S. Securities and Exchange Commission. These reports are available at www.sec.gov or by calling our Investor Relations department at (888) 919-7411 ext. 221. Forward-looking statements speak only as of the date they are posted to this website, unless an earlier date is indicated, and we do not undertake any obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Non-GAAP FinancialMeasures–This presentationincludes certain “non-GAAP financial measures” as defined in Regulation G under the Securities Exchange Act of 1934. Schedules are attached that reconcile the non-GAAP financial measures included in this presentation to the most directly comparable financial measures calculatedand presentedin accordancewith Generally Accepted Accounting Principles in the United States. You should carefully read Progressive Care’s periodic and currentfilings on the OTCQB website for definitions and further explanation and disclosure regarding our use of non-GAAP financial measures and such filings should be read in conjunction with this presentation.
Type your name and email and we'll send you RXMD's investor's presentation in the next few minutes!
.png){kind=logo}
